Serum Type IV Collagen in Various Liver Diseases in Comparison with Serum 7S Collagen, Laminin, and Type III Procollagen Peptide

Overview

Journal J Gastroenterol

Specialty Gastroenterology

Date 1996 Apr 1

PMID 8680545

Citations 7

Authors

C Hirayama

H Suzuki

A Takada

K Fujisawa

K Tanikawa

S Igarashi

Affiliations

Soon will be listed here.

Abstract

The clinical significance of the immunoreactive triple helical domain of type IV collagen in serum was evaluated in 73 healthy controls and 161 patients with various biopsy-proven liver diseases. Although serum levels of type III procollagen peptide were increased in all liver diseases, those of type IV collagen, 7S collagen, and laminin were principally increased in chronic liver diseases associated with hepatic fibrogenesis/fibrosis. In both non-alcoholic and alcoholic liver diseases, 7S collagen was increased in serum, while type IV collagen and laminin in serum were particularly increased in alcoholic liver diseases and in hepatocellular carcinoma, in which latter the sensitivity was greater for type IV collagen than for laminin. Gel filtration analysis in Sephacryl S-400 revealed type IV collagen in serum to be a single molecular form with a molecular weight that correspond to type IV collagen, whereas 7S collagen was recognized as several heterogeneous macromolecules. These findings indicate that serum type IV collagen is derived from the type IV protocollagen pool, and is a sensitive marker for the fibrogenetic process in hepatic basement membranes.

Citing Articles

The association of laminin levels with insulin resistance and non-alcoholic hepatosteatosis.

Altun O, Arman Y, Yoldemir S, Pala A, Gumuskaya P, Ozcan M Diabetol Metab Syndr. 2021; 13(1):60.

PMID: 34092237 PMC: 8183061. DOI: 10.1186/s13098-021-00682-z.

Immunomodulatory Role of the Extracellular Matrix Within the Liver Disease Microenvironment.

McQuitty C, Williams R, Chokshi S, Urbani L Front Immunol. 2020; 11:574276.

PMID: 33262757 PMC: 7686550. DOI: 10.3389/fimmu.2020.574276.

The liver fibrosis niche: Novel insights into the interplay between fibrosis-composing mesenchymal cells, immune cells, endothelial cells, and extracellular matrix.

Matsuda M, Seki E Food Chem Toxicol. 2020; 143:111556.

PMID: 32640349 PMC: 7484466. DOI: 10.1016/j.fct.2020.111556.

Biomarker profile in stable Fontan patients.

Saraf A, De Staercke C, Everitt I, Haouzi A, Ko Y, Jennings S Int J Cardiol. 2020; 305:56-62.

PMID: 31959411 PMC: 7133708. DOI: 10.1016/j.ijcard.2020.01.012.

Iron overload correlates with serum liver fibrotic markers and liver dysfunction: Potential new methods to predict iron overload-related liver fibrosis in thalassemia patients.

Wang M, Liu R, Liang Y, Yang G, Huang Y, Yu C United European Gastroenterol J. 2017; 5(1):94-103.

PMID: 28405327 PMC: 5384551. DOI: 10.1177/2050640616646525.

References

Hayasaka A, Schuppan D, Ohnishi K, Okuda K, Hahn E . Serum concentrations of the carboxyterminal cross-linking domain of procollagen type IV (NC1) and the aminoterminal propeptide of procollagen type III (PIIIP) in chronic liver disease. J Hepatol. 1990; 10(1):17-22. DOI: 10.1016/0168-8278(90)90067-2. View

Clement B, Rescan P, Baffet G, Loreal O, Lehry D, Campion J . Hepatocytes may produce laminin in fibrotic liver and in primary culture. Hepatology. 1988; 8(4):794-803. DOI: 10.1002/hep.1840080417. View

Hahn E, Wick G, Pencev D, Timpl R . Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV, laminin, and fibronectin. Gut. 1980; 21(1):63-71. PMC: 1419572. DOI: 10.1136/gut.21.1.63. View

Bejarano P, NOELKEN M, Suzuki K, Hudson B, Nagase H . Degradation of basement membranes by human matrix metalloproteinase 3 (stromelysin). Biochem J. 1988; 256(2):413-9. PMC: 1135425. DOI: 10.1042/bj2560413. View

Bentsen K, Henriksen J, Bendtsen F, Horslev-Petersen K, Lorenzen I . Splanchnic and renal extraction of circulating type III procollagen aminoterminal propeptide in patients with normal liver function and in patients with alcoholic cirrhosis. Hepatology. 1990; 11(6):957-63. DOI: 10.1002/hep.1840110608. View

Bentsen K, Horn T, Risteli J, Risteli L, Engstrom-Laurent A, Horslev-Petersen K . Serum aminoterminal type III procollagen peptide and the 7S domain of type IV collagen in patients with alcohol abuse. Relation to ultrastructural fibrosis in the acinar zone 3 and to serum hyaluronan. Liver. 1987; 7(6):339-46. DOI: 10.1111/j.1600-0676.1987.tb00365.x. View

Kropf J, Gressner A, Negwer A . Efficacy of serum laminin measurement for diagnosis of fibrotic liver diseases. Clin Chem. 1988; 34(10):2026-30. View

Hartmann D, Trinchet J, Ricard-Blum S, Beaugrand M, Callard P, Ville G . Radioimmunoassay of type I collagen that mainly detects degradation products in serum: application to patients with liver diseases. Clin Chem. 1990; 36(3):421-6. View

Matsumoto E, Muragaki Y, Ooshima A . Increased amount of serum type IV collagen peptide in human liver fibrosis as determined by enzyme-immunoassay with monoclonal antibodies. Acta Pathol Jpn. 1989; 39(4):217-23. DOI: 10.1111/j.1440-1827.1989.tb01504.x. View

10.

Yamada S, Kishimoto Y, Suou T, Kawasaki H, Horie Y . Heterogeneity of antigens related to 7S domain of type IV collagen in serum: application to patients with chronic liver disease. Clin Chim Acta. 1992; 212(1-2):73-8. DOI: 10.1016/0009-8981(92)90139-h. View

11.

Odermatt B, Lang A, Ruttner J, Winterhalter K, Trueb B . Monoclonal antibodies to human type IV collagen: useful reagents to demonstrate the heterotrimeric nature of the molecule. Proc Natl Acad Sci U S A. 1984; 81(23):7343-7. PMC: 392142. DOI: 10.1073/pnas.81.23.7343. View

12.

Bianchi F, Biagini G, Ballardini G, Cenacchi G, Faccani A, Pisi E . Basement membrane production by hepatocytes in chronic liver disease. Hepatology. 1984; 4(6):1167-72. DOI: 10.1002/hep.1840040612. View

13.

Ueno T, Inuzuka S, Torimura T, Oohira H, Ko H, Obata K . Significance of serum type-IV collagen levels in various liver diseases. Measurement with a one-step sandwich enzyme immunoassay using monoclonal antibodies with specificity for pepsin-solubilized type-IV collagen. Scand J Gastroenterol. 1992; 27(6):513-20. DOI: 10.3109/00365529209000114. View

14.

Gressner A, Tittor W, Negwer A . Serum concentrations of N-terminal propeptide of type III procollagen and laminin in the outflow of fibrotic livers compared with liver-distal regions. Hepatogastroenterology. 1986; 33(5):191-5. View

15.

Torimura T, Ueno T, Inuzuka S, Kin M, Ohira H, Kimura Y . The extracellular matrix in hepatocellular carcinoma shows different localization patterns depending on the differentiation and the histological pattern of tumors: immunohistochemical analysis. J Hepatol. 1994; 21(1):37-46. DOI: 10.1016/s0168-8278(94)80134-7. View

16.

Matsuzaki Y, Yoshiga S, Sugitani T, Shoda J, Tanaka N, Osuga T . Enzyme immunoassay of serum type IV collagen in anti-HCV positive chronic liver diseases. Clin Chim Acta. 1993; 221(1-2):209-17. DOI: 10.1016/0009-8981(93)90036-4. View

17.

Sundarraj N, Willson J . Monoclonal antibody to human basement membrane collagen type IV. Immunology. 1982; 47(1):133-40. PMC: 1555500. View

18.

Suou T, Yamada S, Kobayashi J, Hoshino U, Nishimuki E, Kawasaki H . Changes of serum 7S fragment of type IV collagen and N-terminal propeptide of type III procollagen after transcatheter arterial embolization as a model of acute liver injury. Hepatology. 1993; 18(4):809-15. DOI: 10.1002/hep.1840180410. View

19.

Knodell R, Ishak K, Black W, Chen T, Craig R, Kaplowitz N . Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981; 1(5):431-5. DOI: 10.1002/hep.1840010511. View

20.

Risteli J, Rohde H, Timpl R . Sensitive radioimmunoassays for 7 S collagen and laminin: application to serum and tissue studies of basement membranes. Anal Biochem. 1981; 113(2):372-8. DOI: 10.1016/0003-2697(81)90091-9. View